• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

球囊主动脉瓣成形术后的闭合策略比较:缝合介导与胶原基与手动。

Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual.

机构信息

Department of Cariology, Washington Hospital Center, Washington, DC, USA.

出版信息

Catheter Cardiovasc Interv. 2011 Jul 1;78(1):119-24. doi: 10.1002/ccd.22940.

DOI:10.1002/ccd.22940
PMID:21681898
Abstract

OBJECTIVES

To compare complication rates of a collagen-mediated closure device, suture-mediated closure technique and manual compression for access site management following balloon aortic valvuloplasty (BAV).

BACKGROUND

Vascular complications, including perforation, limb ischemia, ateriovenous fistulas, and pseudoaneurysm, are a common source of morbidity in patients undergoing BAV with large bore femoral artery access. The available options for closure of the access site include manual compression, suture-mediated closure devices, and recently reported collagen-based closure devices.

METHODS

The study cohort consisted of 333 patients with severe aortic stenosis undergoing BAV. Patients were divided into four groups according to access closure method: (1) Manual compression in 64 (19.2%); (2) Proglide 6 Fr in 162 (48.6%); (3) Angio-Seal 8 Fr in 89 (26.75%); and (4) Prostar 10 Fr in 18 (5.4%).

RESULTS

There were no significant differences in baseline characteristics among the groups; although the Prostar group was had more males and the Angio-Seal group reported a lower incidence of renal failure and peripheral vascular disease. The Angio-Seal group had shorter procedural duration times compared with the other groups. In the Angio-Seal group (n = 47, 52.8%), a 10 Fr sheath size was primarily used to access the femoral artery, as compared with the manual compression and Proglide groups, which used a 12 Fr sheath in 29 (45.3%) and 66 patients (40.7%), respectively. A 13 Fr sheath was used in the Prostar group (n = 11, 61.1%), P < 0.001. The device failure rate was significantly higher in the Proglide group (n = 20, 12.3%) as compared with Angio-Seal (n = 3, 3.3%) and Prostar groups (n = 1, 5.5%), P = 0.03. Serious vascular complications requiring intervention were significantly higher in the manual compression group (n = 11, 17.1%) compared with the Proglide (n = 11, 6.7%), Angio-Seal (n = 5, 5.6%), and Prostar groups (n = 5, 1%), P < 0.001. The requirement for blood transfusion in the Angio-Seal group was significantly lower (n = 7, 7.8%) as compared with the manual compression (n = 20, 31.2%), Proglide (n = 35, 21.6%), and Prostar groups (n = 5, 27.7%), P < 0.001.

CONCLUSION

In our case series, collagen-based closure devices and suture-mediated closure devices had fewer vascular complications than manual compression for hemostasis following BAV. Patient selection for collagen-based versus suture-mediated closure requires further study.

摘要

目的

比较胶原介导的闭合装置、缝线介导的闭合技术和手动压迫在球囊主动脉瓣成形术(BAV)后用于血管入路管理的并发症发生率。

背景

在接受大口径股动脉入路的 BAV 的患者中,血管并发症(包括穿孔、肢体缺血、动静脉瘘和假性动脉瘤)是发病率的常见来源。血管入路的闭合方法包括手动压迫、缝线介导的闭合装置和最近报道的基于胶原的闭合装置。

方法

研究队列包括 333 例严重主动脉瓣狭窄患者行 BAV。患者根据入路闭合方法分为四组:(1)手动压迫 64 例(19.2%);(2)Proglide 6Fr 162 例(48.6%);(3)Angio-Seal 8Fr 89 例(26.75%);(4)Prostar 10Fr 18 例(5.4%)。

结果

各组间基线特征无显著差异;尽管 Prostar 组男性更多,Angio-Seal 组报告肾功能衰竭和外周血管疾病的发生率较低。与其他组相比,Angio-Seal 组的手术时间更短。在 Angio-Seal 组(n=47,52.8%)中,主要使用 10Fr 鞘管进入股动脉,而手动压迫和 Proglide 组分别有 29 例(45.3%)和 66 例(40.7%)使用 12Fr 鞘管。Prostar 组使用 13Fr 鞘管(n=11,61.1%),P<0.001。Proglide 组(n=20,12.3%)的器械失败率明显高于 Angio-Seal 组(n=3,3.3%)和 Prostar 组(n=1,5.5%),P=0.03。需要介入治疗的严重血管并发症在手动压迫组(n=11,17.1%)明显高于 Proglide 组(n=11,6.7%)、Angio-Seal 组(n=5,5.6%)和 Prostar 组(n=5,1%),P<0.001。Angio-Seal 组的输血需求(n=7,7.8%)明显低于手动压迫组(n=20,31.2%)、Proglide 组(n=35,21.6%)和 Prostar 组(n=5,27.7%),P<0.001。

结论

在我们的病例系列中,胶原基闭合装置和缝线介导的闭合装置在 BAV 后止血时血管并发症较手动压迫少。胶原基与缝线介导闭合装置的患者选择需要进一步研究。

相似文献

1
Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual.球囊主动脉瓣成形术后的闭合策略比较:缝合介导与胶原基与手动。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):119-24. doi: 10.1002/ccd.22940.
2
"Double wire" angio-seal closure technique after balloon aortic valvuloplasty.球囊主动脉瓣成形术后“双钢丝”血管封堵技术。
Catheter Cardiovasc Interv. 2010 Mar 1;75(4):488-92. doi: 10.1002/ccd.22295.
3
Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases.大口径动脉入路装置关闭术在经皮主动脉瓣介入治疗中的应用:Prostar 系统在 118 例中的应用。
Catheter Cardiovasc Interv. 2012 Jan 1;79(1):143-9. doi: 10.1002/ccd.23105. Epub 2011 Dec 8.
4
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices.近年来球囊主动脉瓣成形术后的血管并发症:两种止血装置的发生率及比较
Catheter Cardiovasc Interv. 2018 May 1;91(6):E49-E55. doi: 10.1002/ccd.27328. Epub 2017 Oct 5.
5
Safety and effectiveness of a novel vascular closure device: a prospective study of the ExoSeal compared to the Angio-Seal and ProGlide.一种新型血管闭合装置的安全性和有效性:ExoSeal与Angio-Seal和ProGlide的前瞻性对比研究。
J Endovasc Ther. 2014 Dec;21(6):822-8. doi: 10.1583/14-4744MR.1.
6
Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.经皮经导管主动脉瓣植入术中股动脉入路相关并发症:单Prostar XL装置与双Prostar XL装置闭合的比较
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1255-61. doi: 10.1002/ccd.25966. Epub 2015 Sep 2.
7
A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.一项比较压迫止血、Perclose Proglide血管缝合器和Angio-Seal VIP血管闭合装置用于经皮冠状动脉介入治疗后动脉闭合的随机试验:CAP试验。
Catheter Cardiovasc Interv. 2008 Jan 1;71(1):1-5. doi: 10.1002/ccd.21333.
8
Collagen plug-based vascular closure devices do not decrease vascular and bleeding complications occurring after balloon aortic valvuloplasty.基于胶原塞的血管闭合装置并不能减少球囊主动脉瓣成形术后发生的血管及出血并发症。
Arch Cardiovasc Dis. 2015 Apr;108(4):250-7. doi: 10.1016/j.acvd.2014.11.005. Epub 2015 Mar 6.
9
A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital.一项在地区综合医院进行的随机对照试验,比较血管封堵器(Angio-Seal STS)装置策略的常规使用与传统股动脉止血方法。
Int J Clin Pract. 2007 Mar;61(3):367-72. doi: 10.1111/j.1742-1241.2006.01229.x.
10
Efficacy and safety of antegrade common femoral artery access closure using the Angio-Seal device: experience with 1889 interventions for critical limb ischemia in diabetic patients.经皮顺行股总动脉入路使用 Angio-Seal 装置闭合的疗效和安全性:在 1889 例糖尿病患者严重肢体缺血介入治疗中的应用经验。
J Endovasc Ther. 2010 Jun;17(3):366-75. doi: 10.1583/09-2960.1.

引用本文的文献

1
Vascular Closure Devices versus Manual Compression in Cardiac Interventional Procedures: Systematic Review and Meta-Analysis.血管闭合装置与心脏介入手术中的手动压迫:系统评价和荟萃分析。
Cardiovasc Ther. 2022 Sep 9;2022:8569188. doi: 10.1155/2022/8569188. eCollection 2022.
2
Adjunctive use of Angio-Seal closure device following transcatheter aortic valve implantation via percutaneous transfemoral approach with incomplete hemostasis after modified Perclose ProGlide preclosure technique.经皮股动脉途径行导管主动脉瓣植入术后,采用改良Perclose ProGlide预闭合技术后止血不完全时,辅助使用Angio-Seal闭合装置。
Proc (Bayl Univ Med Cent). 2019 Jan 11;32(1):34-36. doi: 10.1080/08998280.2018.1524102. eCollection 2019 Jan.
3
Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: a narrative review.经导管主动脉瓣植入时代的经皮球囊主动脉瓣成形术:一项叙述性综述。
Open Heart. 2016 Dec 7;3(2):e000421. doi: 10.1136/openhrt-2016-000421. eCollection 2016.
4
The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: a sub-analysis of the BRAVO study.球囊主动脉瓣成形术中血管闭合装置的应用及其对主要出血和净不良临床事件(NACEs)的影响:BRAVO 研究的亚分析。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):148-53. doi: 10.1002/ccd.24892. Epub 2013 Mar 25.
5
Safety and Efficacy of the Prostar XL Vascular Closing Device for Percutaneous Closure of Large Arterial Access Sites.用于经皮闭合大动脉穿刺部位的Prostar XL血管闭合装置的安全性和有效性。
Radiol Res Pract. 2013;2013:875484. doi: 10.1155/2013/875484. Epub 2013 Jan 14.